Paeonol promotes the phagocytic ability of macrophages through confining HMGB1 to the nucleus

Jifei Miao,Peng Ye,Jiao Lan,Sen Ye,Jun Zhong,Austin Gresham,Siyan Li,Aijia You,Xianjie Chen,Xiaoyi Liu,Hui Li
DOI: https://doi.org/10.1016/j.intimp.2020.107068
IF: 5.714
2020-12-01
International Immunopharmacology
Abstract:<p>Phagocytosis is a basic immune response to the pathogens invading. Immunosuppression may occur in diseases like sepsis and cancer, and cause a low phagocytic ability of phagocytes. High mobility group protein B1 (HMGB1) is a DNA chaperone which is closely related to the phagocytosis. Nonetheless, its influence on phagocytosis is still controversial. We found that paeonol could inhibit the translocation of HMGB1 from the nucleus to the cytoplasm, it may have an impact on phagocytosis. In the present study, we performed <em>in vivo</em> and <em>in vitro</em> experiments to investigate the influence of paeonol on phagocytosis. Zymosan was used to test the phagocytic function of macrophages. Our results showed that paeonol promotes the phagocytosis of macrophages through confining HMGB1 to the nucleus. Through interacting with P53, the nuclear HMGB1 keep it in the nucleus and decrease the negative influence of P53 on the phosphorylation of Focal Adhesion Kinase (FAK). The increasing of phosphorylated FAK promotes the formation of pseudopod and enhances the phagocytic ability of macrophages.</p>
pharmacology & pharmacy,immunology
What problem does this paper attempt to address?